Since June 2025, Vertex Pharmaceuticals has been in a holding pattern, posting a small return of 0.5% while floating around ...

These stocks have promising assets in their portfolios that could help make their valuations soar in the future.

The best defensive stocks to balance risk and return combine durable cash flows, essential services, and key growth metrics.

The financing follows a strategic shift for Orum, which shelved its original lead program and is now pursuing a potential ...

India - Pre-Grant Opposition Not Permitted After Signing Of Grant: Delhi High Court Affirms. Legal News and Analysis - India ...

BENTONVILLE, Ark., Dec. 17, 2025 /PRNewswire/ -- HFA Architecture + Engineering announced today that Sherwood Butler has joined the employee-owned firm as Vice President. He will lead HFA's growing ...

Analysts project the U.S. diabetes market will surge past $75 billion by 2031, driven by advanced cell therapies and continuous glucose monitoring systems transforming patient care [3]. Regenerative ...

Royalty Pharma is acquiring a low-single digit pre-existing royalty on worldwide net sales on each of Nuvalent’s neladalkib and zidesamtinib from an undisclosed third party for up to $315 million. The ...

Founded in 1964, Alger is recognized as a pioneer of growth-style investment management. Privately-owned and headquartered in New York City, Alger can help "Unlock Your Growth Potential" through a ...

If the trends of the first three quarters continue in the fourth, the amount of money raised by Bay State startups could be ...

Microsoft shares underperformed due to concerns about its relationship with OpenAI following the Oracle/OpenAI deal ...

The following players span a variety of industries, so if you pick up more than one, you may gain in diversification.